Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide

Hiroko Sano, Tomomi Noguchi, Aya Tanatani, Yuichi Hashimoto, Hiroyuki Miyachi

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

A series of substituted indoline and indole derivatives with cyclooxygenase (COX)-inhibitory activity was prepared during our structural development studies based on thalidomide as a multi-template lead compound. Structure-activity relationship studies indicated that the nature of the substituent introduced at the benzene ring of the indoline (indole) backbone, and the length and type of the linking group between the nitrogen atom of indoline (indole) and the N-substituent are important for the activity. This study has led to the identification of COX-1-selective inhibitors, and these should be useful not only as pharmacological tools to investigate the physiology and pathophysiology of COX, but also as sophisticated leads for the development of novel drugs to treat COX-associated diseases, such as inflammatory diseases, and cancer.

Original languageEnglish
Pages (from-to)3079-3091
Number of pages13
JournalBioorganic and Medicinal Chemistry
Volume13
Issue number9
DOIs
Publication statusPublished - May 1 2005
Externally publishedYes

Fingerprint

Thalidomide
Cyclooxygenase Inhibitors
Prostaglandin-Endoperoxide Synthases
Lead compounds
Cyclooxygenase 1
Physiology
Structure-Activity Relationship
Benzene
Nitrogen
Pharmacology
Derivatives
Atoms
indoline
Pharmaceutical Preparations
Neoplasms

Keywords

  • COX-1
  • COX-1 selectivity
  • Indole derivatives
  • Indoline derivatives

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide. / Sano, Hiroko; Noguchi, Tomomi; Tanatani, Aya; Hashimoto, Yuichi; Miyachi, Hiroyuki.

In: Bioorganic and Medicinal Chemistry, Vol. 13, No. 9, 01.05.2005, p. 3079-3091.

Research output: Contribution to journalArticle

Sano, Hiroko ; Noguchi, Tomomi ; Tanatani, Aya ; Hashimoto, Yuichi ; Miyachi, Hiroyuki. / Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide. In: Bioorganic and Medicinal Chemistry. 2005 ; Vol. 13, No. 9. pp. 3079-3091.
@article{3ab8978b35bd47418294a5f82943b6aa,
title = "Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide",
abstract = "A series of substituted indoline and indole derivatives with cyclooxygenase (COX)-inhibitory activity was prepared during our structural development studies based on thalidomide as a multi-template lead compound. Structure-activity relationship studies indicated that the nature of the substituent introduced at the benzene ring of the indoline (indole) backbone, and the length and type of the linking group between the nitrogen atom of indoline (indole) and the N-substituent are important for the activity. This study has led to the identification of COX-1-selective inhibitors, and these should be useful not only as pharmacological tools to investigate the physiology and pathophysiology of COX, but also as sophisticated leads for the development of novel drugs to treat COX-associated diseases, such as inflammatory diseases, and cancer.",
keywords = "COX-1, COX-1 selectivity, Indole derivatives, Indoline derivatives",
author = "Hiroko Sano and Tomomi Noguchi and Aya Tanatani and Yuichi Hashimoto and Hiroyuki Miyachi",
year = "2005",
month = "5",
day = "1",
doi = "10.1016/j.bmc.2005.03.002",
language = "English",
volume = "13",
pages = "3079--3091",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide

AU - Sano, Hiroko

AU - Noguchi, Tomomi

AU - Tanatani, Aya

AU - Hashimoto, Yuichi

AU - Miyachi, Hiroyuki

PY - 2005/5/1

Y1 - 2005/5/1

N2 - A series of substituted indoline and indole derivatives with cyclooxygenase (COX)-inhibitory activity was prepared during our structural development studies based on thalidomide as a multi-template lead compound. Structure-activity relationship studies indicated that the nature of the substituent introduced at the benzene ring of the indoline (indole) backbone, and the length and type of the linking group between the nitrogen atom of indoline (indole) and the N-substituent are important for the activity. This study has led to the identification of COX-1-selective inhibitors, and these should be useful not only as pharmacological tools to investigate the physiology and pathophysiology of COX, but also as sophisticated leads for the development of novel drugs to treat COX-associated diseases, such as inflammatory diseases, and cancer.

AB - A series of substituted indoline and indole derivatives with cyclooxygenase (COX)-inhibitory activity was prepared during our structural development studies based on thalidomide as a multi-template lead compound. Structure-activity relationship studies indicated that the nature of the substituent introduced at the benzene ring of the indoline (indole) backbone, and the length and type of the linking group between the nitrogen atom of indoline (indole) and the N-substituent are important for the activity. This study has led to the identification of COX-1-selective inhibitors, and these should be useful not only as pharmacological tools to investigate the physiology and pathophysiology of COX, but also as sophisticated leads for the development of novel drugs to treat COX-associated diseases, such as inflammatory diseases, and cancer.

KW - COX-1

KW - COX-1 selectivity

KW - Indole derivatives

KW - Indoline derivatives

UR - http://www.scopus.com/inward/record.url?scp=16244383547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244383547&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2005.03.002

DO - 10.1016/j.bmc.2005.03.002

M3 - Article

VL - 13

SP - 3079

EP - 3091

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 9

ER -